Quarterly report pursuant to Section 13 or 15(d)

Equity Method Investments (Tables)

v3.20.4
Equity Method Investments (Tables)
 9 Months Ended
Nov. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Equity method investments
Our equity method investments are as follows:
November 30, 2020 February 29, 2020
Carrying Value Ownership Percentage Carrying Value Ownership Percentage
(in millions)
Canopy Equity Method Investment $ 2,738.7  38.2  % $ 2,911.7  35.3  %
Other equity method investments (1)
221.2 
20%-50%
 182.2 
20%-50%
$ 2,959.9  $ 3,093.9 
(1)The other equity method investments balance at November 30, 2020, and February 29, 2020, excludes investments reclassified to assets held for sale.
Equity in earnings (losses) from the Canopy Equity Method Investment and related activities (see table below) include, among other items, restructuring and other strategic business development costs, the amortization of the fair value adjustments associated with the definite-lived intangible assets over their estimated useful lives, the flow through of inventory step-up, unrealized gains (losses) associated with changes in our Canopy ownership percentage resulting from periodic equity issuances made by Canopy, and our share of Canopy’s additional loss resulting from the June 2019 Warrant Modification (as defined below) of $409.0 million (the “June 2019 Warrant Modification Loss”).
Amounts included in our consolidated results of operations for each period are as follows:

For the Nine Months
Ended November 30,		 For the Three Months
Ended November 30,
2020 2019 2020 2019
(in millions)
Equity in earnings (losses) from Canopy and related activities $ (421.0) $ (544.2) $ (12.4) $ 46.2 
The following table presents summarized financial information for Canopy presented in accordance with U.S. GAAP. We recognize our equity in earnings (losses) for Canopy on a two-month lag. Accordingly, we recognized our share of Canopy’s earnings (losses) for the periods January through September 2020 and January through September 2019 in our nine months ended November 30, 2020, and November 30, 2019, results, respectively. We recognized our share of Canopy’s earnings (losses) for the periods July through September 2020 and July through September 2019 in our three months ended November 30, 2020, and November 30, 2019, results, respectively. The amounts shown represent 100% of Canopy’s results of operations for the respective periods, however, the results of operations for the nine months ended November 30, 2019, exclude the impact of the June 2019 Warrant Modification Loss because it was recorded by Canopy within equity. The nine months and three months ended November 30, 2020, includes costs designed to improve Canopy’s organizational focus, streamline operations, and align production capability with projected demand.
For the Nine Months
Ended November 30,		 For the Three Months
Ended November 30,
2020 2019 2020 2019
(in millions)
Net sales $ 261.5  $ 196.4  $ 101.5  $ 58.0 
Gross profit (loss) $ (33.0) $ 13.8  $ 19.6  $ (7.3)
Net income (loss) $ (1,138.7) $ (246.0) $ (72.5) $ 172.6 
Net income (loss) attributable to Canopy $ (1,055.8) $ (245.4) $ (24.1) $ 185.0